Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Webcast

Iveric Bio to Present at Upcoming Investor Conferences


IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Iveric Bio management will participate in fireside chats at the following investor conferences in November:

Investors and the general public are invited to access the live webcasts of the fireside chats on the Investor / Events & Presentations section of the Iveric Bio website at www.ivericbio.com. An archived replay of each of the presentations will be available on the Company's website immediately following each conference and for at least 30 days thereafter.

About Iveric Bio

Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients' lives by delivering high-quality, safe and effective treatments designed to address debilitating retinal diseases including earlier stages of age-related macular degeneration. For more information on the Company, please visit www.ivericbio.com.

Forward-looking Statements

Any statements in this press release or made during the presentation referenced herein about Iveric Bio's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including those described in the "Risk Factors" section of public filings made by Iveric Bio with the U.S. Securities and Exchange Commission. Any forward-looking statements represent Iveric Bio's views only as of the date of this press release or the presentation, as applicable. Iveric Bio anticipates that subsequent events and developments may cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so unless required by law.

ISEE-G


These press releases may also interest you

at 18:15
The global lithium-sulfur battery market size is estimated to grow by USD 3.92 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  44.97%  during the forecast period. Harmful usage of lead batteries leads to...

at 18:05
The global flexible packaging market size is estimated to grow by USD 51.6 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.97% during the forecast period. Rise in demand for pouch packaging solutions is...

at 18:00
The global 21700 lithium-ion battery market size is estimated to grow by USD 6.54 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 21.22% during the forecast period. Improved capacity and performance of...

at 17:50
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:40
The global smart factory market size is estimated to grow by USD 97.1 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 10.87% during the forecast period. Increasing focus of vendors on setting up new smart...

at 17:35
The global touch controller IC market  size is estimated to grow by USD 30.91 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 29.73%  during the forecast period. Increasing sales of electronic devices...



News published on and distributed by: